Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

To improve patient quality of life and reduce health care costs, many conditions formerly thought to require inpatient care are now treated in the outpatient setting. Outpatient induction chemotherapy for acute myeloid leukemia (AML) may confer similar benefits. This possibility prompted a pilot stu...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Blood Adv
मुख्य लेखकों: Mabrey, Frances Linzee, Gardner, Kelda M., Shannon Dorcy, Kathleen, Perdue, Andrea, Smith, Heather A., Davis, Alicyn M., Hammer, Cody, Rizzuto, Donelle, Jones, Sunny, Quach, Kim, Scott, Bart L., Hendrie, Paul C., Percival, Mary-Elizabeth M., Walter, Roland B., Appelbaum, Frederick R., Estey, Elihu H., Becker, Pamela S.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Hematology 2020
विषय:
Clinical Trials and Observations
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042997/
https://ncbi.nlm.nih.gov/pubmed/32074276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000707
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन